ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
Dow Jones
39.069,59
0,01%
Euro vs US Dollar
1,08535
0,38%
Bitcoin
68.793,92
1,28%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Therapeutics Acquisition Corp (TXAC)

  7. Therapeutics Acquisition Corp (TXAC) News

TXAC

Therapeutics Acquisition (TXAC)

Therapeutics Acquisition Corp
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TXAC
DatumZeitQuelleÜberschriftSymbolFirma
15/06/202300h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
15/06/202300h15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TXACTherapeutics Acquisition Corp
05/06/202323h37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
05/06/202323h36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
05/06/202323h36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
05/06/202323h36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
05/06/202323h36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
05/06/202322h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXACTherapeutics Acquisition Corp
01/05/202319h58Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:TXACTherapeutics Acquisition Corp
27/04/202314h31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TXACTherapeutics Acquisition Corp
27/03/202313h55Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TXACTherapeutics Acquisition Corp
14/02/202318h01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TXACTherapeutics Acquisition Corp
07/02/202314h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXACTherapeutics Acquisition Corp
03/02/202318h12Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TXACTherapeutics Acquisition Corp
29/11/202200h30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
29/11/202200h30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
29/11/202200h29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
23/11/202218h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
22/11/202222h22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TXACTherapeutics Acquisition Corp
21/11/202223h53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
14/11/202213h23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TXACTherapeutics Acquisition Corp
26/09/202223h29Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TXACTherapeutics Acquisition Corp
26/09/202222h55Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TXACTherapeutics Acquisition Corp
16/09/202222h30Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TXACTherapeutics Acquisition Corp
14/09/202222h15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXACTherapeutics Acquisition Corp
14/09/202222h13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TXACTherapeutics Acquisition Corp
13/09/202222h12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXACTherapeutics Acquisition Corp
12/09/202213h55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXACTherapeutics Acquisition Corp
06/09/202214h12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXACTherapeutics Acquisition Corp
29/08/202223h02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TXACTherapeutics Acquisition Corp
 Showing the most relevant articles for your search:NASDAQ:TXAC

Kürzlich von Ihnen besucht

BIT
P20CY7
NLBNPIT20CY7 20240620 18...
XE
UPAB
United Parcel Service
KOSPI
008420
Moonbae Steel
EU
INCEM
Casam Etf Cem Inav
BIT
P1TFY0
NLBNPIT1TFY0 20240621 80
BIT
P1XYN6
NLBNPIT1XYN6 20240621 21...
NYSE
MTE
Mahanagar
COIN
SDAOOUST
BIT
P1TDA5
NLBNPIT1TDA5 20240621 120
BIT
F17280
Vontobel Financial Produ...
ASX
FXPKOF
BIT
P1XF32
NLBNPIT1XF32 20240619 17...
ASX
BHPKOB
USOTC
AJLGF
AJ Lucas (PK)
BIT
P1VXS1
NLBNPIT1VXS1 20351221 4....
BIT
P21XN4
NLBNPIT21XN4 20351221 10...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten